The global anti-venom market is witnessing substantial growth due to the increasing incidence of snakebites, scorpion stings, and other venomous animal envenomations, particularly in tropical and subtropical regions. Anti-venom is a biological product developed using antibodies that neutralize toxins present in venom, making it an essential treatment for preventing severe complications and fatalities resulting from venomous bites and stings. The global anti-venom market size was valued at USD 1.28 billion in 2024 and is projected to grow from USD 1.38 billion in 2025 to reach USD 2.57 billion by 2033, growing at a CAGR of 8.9% during the forecast period (2025–2033). The rising burden of venomous animal attacks, increasing government initiatives to improve access to life-saving treatments, and growing investments in biotechnology research are major factors driving market growth.…